Baris Gencer1, Javed Butler2, Douglas C Bauer3, Reto Auer4, Andreas Kalogeropoulos2, Pedro Marques-Vidal5, William B Applegate6, Suzanne Satterfield7, Tamara Harris8, Anne Newman9, Eric Vittinghoff4, Nicolas Rodondi10. 1. Cardiology Division, Department of Medicine, Geneva University Hospital, Geneva, Switzerland. 2. Cardiology Division, Emory University, Atlanta, GA. 3. Department of Medicine, University of California, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA. 4. Department of Epidemiology and Biostatistics, University of California, San Francisco, CA. 5. Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland; Clinical Research Centre, Lausanne University Hospital, Lausanne, Switzerland. 6. Internal Medicine and Geriatric Medicine, Wake Forest University Baptist Medical Center, Winston Salem, NC. 7. Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN. 8. Geriatric Epidemiology Section, National Institute on Aging, Bethesda, MD. 9. Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA. 10. Department of General Internal Medicine, University of Bern, Bern, Switzerland. Electronic address: Nicolas.Rodondi@insel.ch.
Abstract
UNLABELLED: Unless effective preventive strategies are implemented, aging of the population will result in a significant worsening of the heart failure (HF) epidemic. Few data exist on whether baseline electrocardiographic (ECG) abnormalities can refine risk prediction for HF. METHODS: We examined a prospective cohort of 2,915 participants aged 70 to 79 years without preexisting HF, enrolled between April 1997 and June 1998 in the Health, Aging, and Body Composition (Health ABC) study. Minnesota Code was used to define major and minor ECG abnormalities at baseline and at year 4 follow-up. Using Cox models, we assessed (1) the association between ECG abnormalities and incident HF and (2) the incremental value of adding ECG to the Health ABC HF Risk Score using the net reclassification index. RESULTS: At baseline, 380 participants (13.0%) had minor, and 620 (21.3%) had major ECG abnormalities. During a median follow-up of 11.4 years, 485 participants (16.6%) developed incident HF. After adjusting for the Health ABC HF Risk Score variables, the hazard ratio (HR) was 1.27 (95% CI 0.96-1.68) for minor and 1.99 (95% CI 1.61-2.44) for major ECG abnormalities. At year 4, 263 participants developed new and 549 had persistent abnormalities; both were associated with increased subsequent HF risk (HR 1.94, 95% CI 1.38-2.72 for new and HR 2.35, 95% CI 1.82-3.02 for persistent ECG abnormalities). Baseline ECG correctly reclassified 10.5% of patients with HF events, 0.8% of those without HF events, and 1.4% of the overall population. The net reclassification index across the Health ABC HF risk categories was 0.11 (95% CI 0.03-0.19). CONCLUSIONS: Among older adults, baseline and new ECG abnormalities are independently associated with increased risk of HF. The contribution of ECG screening for targeted prevention of HF should be evaluated in clinical trials.
UNLABELLED: Unless effective preventive strategies are implemented, aging of the population will result in a significant worsening of the heart failure (HF) epidemic. Few data exist on whether baseline electrocardiographic (ECG) abnormalities can refine risk prediction for HF. METHODS: We examined a prospective cohort of 2,915 participants aged 70 to 79 years without preexisting HF, enrolled between April 1997 and June 1998 in the Health, Aging, and Body Composition (Health ABC) study. Minnesota Code was used to define major and minor ECG abnormalities at baseline and at year 4 follow-up. Using Cox models, we assessed (1) the association between ECG abnormalities and incident HF and (2) the incremental value of adding ECG to the Health ABC HF Risk Score using the net reclassification index. RESULTS: At baseline, 380 participants (13.0%) had minor, and 620 (21.3%) had major ECG abnormalities. During a median follow-up of 11.4 years, 485 participants (16.6%) developed incident HF. After adjusting for the Health ABC HF Risk Score variables, the hazard ratio (HR) was 1.27 (95% CI 0.96-1.68) for minor and 1.99 (95% CI 1.61-2.44) for major ECG abnormalities. At year 4, 263 participants developed new and 549 had persistent abnormalities; both were associated with increased subsequent HF risk (HR 1.94, 95% CI 1.38-2.72 for new and HR 2.35, 95% CI 1.82-3.02 for persistent ECG abnormalities). Baseline ECG correctly reclassified 10.5% of patients with HF events, 0.8% of those without HF events, and 1.4% of the overall population. The net reclassification index across the Health ABC HF risk categories was 0.11 (95% CI 0.03-0.19). CONCLUSIONS: Among older adults, baseline and new ECG abnormalities are independently associated with increased risk of HF. The contribution of ECG screening for targeted prevention of HF should be evaluated in clinical trials.
Authors: L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman Journal: Ann Epidemiol Date: 1991-02 Impact factor: 3.797
Authors: Nicolas Rodondi; Anne B Newman; Eric Vittinghoff; Nathalie de Rekeneire; Suzanne Satterfield; Tamara B Harris; Douglas C Bauer Journal: Arch Intern Med Date: 2005-11-28
Authors: M L Daviglus; Y Liao; P Greenland; A R Dyer; K Liu; X Xie; C F Huang; R J Prineas; J Stamler Journal: JAMA Date: 1999-02-10 Impact factor: 56.272
Authors: Ravi Dhingra; Michael J Pencina; Thomas J Wang; Byung-Ho Nam; Emelia J Benjamin; Daniel Levy; Martin G Larson; William B Kannel; Ralph B D'Agostino; Ramachandran S Vasan Journal: Hypertension Date: 2006-04-03 Impact factor: 10.190
Authors: Véronique L Roger; Susan A Weston; Margaret M Redfield; Jens P Hellermann-Homan; Jill Killian; Barbara P Yawn; Steven J Jacobsen Journal: JAMA Date: 2004-07-21 Impact factor: 56.272
Authors: Sanjay Venkatesh; Wesley T O'Neal; Stephen T Broughton; Amit J Shah; Elsayed Z Soliman Journal: Am J Cardiol Date: 2016-12-18 Impact factor: 2.778
Authors: Stephen T Broughton; Wesley T O'Neal; Mouaz Al-Mallah; David A Bluemke; Susan R Heckbert; Joao A C Lima; Elsayed Z Soliman Journal: Int J Cardiol Date: 2017-12-15 Impact factor: 4.164
Authors: Ayodipupo S Oguntade; IkeOluwapo O Ajayi; Akinyemi Aje; Adewole A Adebiyi; Okechukwu S Ogah; Abiodun M Adeoye Journal: J Saudi Heart Assoc Date: 2020-08-19